Showing 1621-1630 of 2880 results for "".
- In a Week of Surprising Acquisitions, Will Syneron Be Next?https://modernaesthetics.com/news/in-a-week-of-surprising-acquisitions-will-syneron-be-next/2472276/Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners is looking to buy Syneron Medical for $350-$400 million. According to Israeli finan
- ISAPS 2017: US Still Reigns As Cosmetic Surgery Capitol of the Worldhttps://modernaesthetics.com/news/isaps-2017-us-still-reigns-as-cosmetic-surgery-capitol-of-the-world/2471994/The USA, Brazil, Japan, Italy and Mexico continue to perform the most cosmetic surgery procedures across the globe, according to the 2017 statistics from the International Society of Aesthetic Plastic Surgery (ISAPS). These top five countries account f
- Study: Patients Prefer Top-to-Bottom Injection Techniquehttps://modernaesthetics.com/news/study-patients-prefer-top-to-bottom-injection-technique/2473627/Orienting the needle from top to bottom, taking into account migration to the upper lip, led to greater patient satisfaction in a study of lip rejuvenation techniques published in Cureus. Dr. Omer Buhsem conducted a randomized retrospective study of 216 female patients, using a top-to-b
- Bliss Scores B Corp Certificationhttps://modernaesthetics.com/news/bliss-scores-b-corp-certification/2473108/Bliss is the first-ever skincare brand sold at mass and drug to achieve B Corp Certification. This certification confirms that Bliss meets the highest standards of verified social and environmental performance, public transparency, and legal accountability to
- Jacob Chacko, MD Joins Bonti's Board of Directorshttps://modernaesthetics.com/news/jacob-chackomd-joins-bontis-board-of-directors/2472135/Jacob Chacko, MD has joined Bonti’s Board of Directors. Dr. Chacko has served as the Chief Financial Officer of Ignyta, Inc. since May 2014. At Ignyta, he leads multiple functions, including Finance, Accounting, Investor Relations, Comm
- JUVÉDERM Day Returns with Limited-Time Offers Through Rewards Programhttps://modernaesthetics.com/news/juvederm-day-returns-limited-time-offers-through-rewards-program/2482957/Members of JUVÉDERM’s Alle loyalty rewards program will have an opportunity to purchase “buy one, get one” gift cards as part of JUVÉDERM Day on August 20, according to Allergan Aesthetics, an AbbVie company. Details of the exclusive, limited limited-time offers are as follows: •
- News You Can Use: RVL Rolls Out New Prescription E-commerce Platform, ELEVATEhttps://modernaesthetics.com/news/news-you-can-use-rvl-rolls-out-new-prescription-e-commerce-platform-elevate/2473442/RVL Pharmaceuticals is launching a prescription e-commerce platform. ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional&nb
- iCRYO to Bring BTL Devices to Franchiseshttps://modernaesthetics.com/news/icryo-to-bring-btl-devices-to-franchises/2473353/iCRYO is partnering with BTL Industries to bring BTL’s suite of devices to their franchises. “We are going into a multi-year purchasing agreement to onboard several hundred devices over that time period. We are working on launching our "EMsuite" within the iC
- Cutera Closes Public Stock Offeringhttps://modernaesthetics.com/news/cutera-closes-public-stock-offering/2472917/Cutera, Inc. has closed its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its co
- Business News: Hologic to Offload Cynosure for $205Mhttps://modernaesthetics.com/news/business-news-hologic-to-offload-cynosure-for-205m/2472847/Hologic is selling Cynosure medical aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice for a total purchase price of $205 million in cash, subject to certain closing adjustments. This is a tenth of the $1.6B that Hologic, a women